학술논문
TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer
Document Type
Artikel
Author
Fagerholm, R; Khan, S; Schmidt, MK; Garcia-Closas, M; Heikkila, P; Saarela, J; Beesley, J; Jamshidi, M; Aittomaki, K; Liu, JJ; Ali, HR; Andrulis, IL; Beckmann, MW; Behrens, S; Blows, FM; Brenner, H; Chang-Claude, J; Couch, FJ; Czene, K; Fasching, PA; Figueroa, J; Floris, G; Glendon, G; Guo, Q; Hall, P; Hallberg, E; Hamann, U; Holleczek, B; Hooning, MJ; Hopper, JL; Jager, A; Kabisch, M; Keeman, R; Kosma, VM; Lambrechts, D; Lindblom, A; Mannermaa, A; Margolin, S; Provenzano, E; Shah, M; Southey, MC; Dennis, J; Lush, M; Michailidou, K; Wang, Q; Bolla, MK; Dunning, AM; Easton, DF; Pharoah, PDP; Chenevix-Trench, G; Blomqvist, C; Nevanlinna, H
Source
Oncotarget. 8(11):18381-18398
Subject
Language
English
English
English
ISSN
1949-2553